Li Tao, Secretary of the Party Leadership Group and Director of Shandong Provincial Food and Drug Administration, visited Shandong Jincheng Pharmaceutical Group Co., Ltd. for investigation
Li Tao, Secretary of the Party Leadership Group and Director of Shandong Provincial Food and Drug Administration, visited Shandong Jincheng Pharmaceutical Group Co., Ltd. for investigation
On October 30, Li Tao, a member of the Party Leadership Group of Shandong Provincial Administration for Market Regulation, Secretary of the Party Leadership Group and Director of the Provincial Food and Drug Administration, and his delegation visited Shandong Jincheng Pharmaceutical Group Co., Ltd. to investigate the development of the synthetic biology pharmaceutical industry. Guo Yihua, Secretary of the Party Leadership Group and Director of the Zibo Municipal Administration for Market Regulation, Cheng Qin, Secretary of the Zichuan District Committee, Zhao Yeqing, Group Chairman, President Li Jiaquan, and Chief Engineer Zheng Gengxiu accompanied the investigation.
In the "Jincheng Synthetic Biology Intelligent Innovation Space" technology exhibition hall, Li Tao learned in detail about Jincheng's synthetic biology, medical and health industry and corporate development. Group Chairman Zhao Yeqing introduced the industrial layout of Shandong Jincheng Pharmaceutical Group Co., Ltd. and the development status of synthetic biology and other industrial sectors.
In recent years, Shandong Jincheng Pharmaceutical Group Co., Ltd. firmly implements the overall development strategy of "12345", insists on focusing on the main business, pooling resources, and concentrating on innovation. Centering on the industrial positioning of "based on big medicine and expanding big health", it focuses on the fields of "pharmaceutical chemicals, synthetic biology, women's health technology, high-end anti-infections, and new tobacco" , taking the "synthetic biology" industry as the main direction and core business of future development, relying on the advantages of the "chemical synthesis + synthetic biology" dual-synthesis research and production platform and independent scientific research and innovation system, striving to build a first-class synthetic biology platform enterprise and further promote the development of synthetic biology and the medical and health industry.
During the investigation, Li Tao fully affirmed Shandong Jincheng Pharmaceutical Group Co., Ltd.'s approach and development results of accelerating the innovative development of synthetic biology and pharmaceutical industries by relying on the advantages of the "dual synthesis" platform and high-level planning and layout. It is hoped that enterprises will give full play to the advantages of scientific research technology and platforms, make full use of industrial support policies, continue to work hard on the development track of synthetic biology and medical and health industries, continue to achieve new breakthroughs, and promote the high-quality development of the province's medical and health industry with new quality productivity.
(Contributed by Beijing Management Center)